Literature DB >> 30935758

Lifelong Congenital Urology: The Challenges for Patients and Surgeons.

Dan Wood1, Andrew Baird2, Luca Carmignani3, Gunter De Win4, Piet Hoebeke5, Gundela Holmdahl6, Gianantonio Manzoni7, Rien J M Nijman8, Claire Taylor9, Serdar Tekgul10.   

Abstract

CONTEXT: Patients born with complex congenital genitourinary anomalies (including bladder exstrophy, cloacal exstrophy, epispadias, neurogenic bladder, hypospadias and posterior urethral valves) often require major reconstructive surgery in childhood. These conditions, their treatment and sequelae require lifelong follow-up. This has created the need for adult urologists to provide care as these patients grow into adults.
OBJECTIVE: To evaluate current strategies for transition and provide a current position statement with examples of the challenges faced by patients and their health care teams as a result of these conditions and their treatment. EVIDENCE ACQUISITION: Each of the authors was asked to provide a 500-word synthesis, based on current literature; to highlight the challenges faced in an area of their expertise. EVIDENCE SYNTHESIS: The authors assembled in March 2018 to form a consensus based on the data gathered. The aforementioned sections were reviewed and following the consensus discussion the paper was formulated and reviewed.
CONCLUSIONS: Lifelong care of congenital problems is challenging and essential for many but not all. Expertise is needed to provide the best care for patients and make the best use of resources. Specialist centres appear to be the most effective and safe model. In the long term it would be ideal to establish an evidence base focused on the common long-term problems with these conditions to ensure excellent care with appropriate expertise. PATIENT
SUMMARY: Patients born with complex congenital anomalies of the genitourinary system require specialist care in childhood. Many will need lifelong care to manage their condition and the treatment of it. There is growing interest in this area of medicine and this consensus statement addresses the need for lifelong care in this group. The aim is to ensure that all patients that need care at any age are able to find what they need.
Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolescent urology; Bladder exstrophy; Epispadias; Exstrophy; Hypospadias; Neurogenic bladder; Posterior urethral valves; Transition

Year:  2019        PMID: 30935758     DOI: 10.1016/j.eururo.2019.03.019

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  5 in total

1.  Challenges in pediatric urologic practice: a lifelong view.

Authors:  John S Wiener; Nina Huck; Anne-Sophie Blais; Mandy Rickard; Armando Lorenzo; Heather N McCaffrey Di Carlo; Margaret G Mueller; Raimund Stein
Journal:  World J Urol       Date:  2020-04-23       Impact factor: 4.226

Review 2.  Hypospadias: lessons learned. An overview of incidence, epidemiology, surgery, research, complications, and outcomes.

Authors:  Dan Wood; Duncan Wilcox
Journal:  Int J Impot Res       Date:  2022-03-29       Impact factor: 2.896

3.  A biomimetic hyaluronic acid-silk fibroin nanofiber scaffold promoting regeneration of transected urothelium.

Authors:  Yuqing Niu; Massimiliano Galluzzi; Fuming Deng; Zhang Zhao; Ming Fu; Liang Su; Weitang Sun; Wei Jia; Huimin Xia
Journal:  Bioeng Transl Med       Date:  2021-11-18

4.  Evaluation of surgical procedures of mouse urethra by visualization and the formation of fistula.

Authors:  Taiju Hyuga; Daiki Hashimoto; Daisuke Matsumaru; Shinji Kumegawa; Shinichi Asamura; Kentaro Suzuki; Kei-Ichi Katayama; Shigeru Nakamura; Hideo Nakai; Gen Yamada
Journal:  Sci Rep       Date:  2020-10-26       Impact factor: 4.379

5.  Sexual function in adult patients who have undergone augmentation surgery in childhood: what is really important?

Authors:  Beatriz Bañuelos Marco; Manuela Hiess; Raimund Stein; Ricardo Gonzalez; Anja Lingnau; Dan Wood; Anna Radford; Bernhard Haid
Journal:  Int J Impot Res       Date:  2020-10-10       Impact factor: 2.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.